Cargando…
Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study
We aimed to compare the overall survival (OS) of patients with bone metastases (BM) from solid tumors after standard‐dose radiotherapy ([RT]; 30 Gy administered in 10 fractions; EQD(2Gy) = 32.5 Gy) and dose‐escalated RT (EQD(2Gy) > 32.5 Gy). We retrospectively reviewed the clinical charts of 1795...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603838/ https://www.ncbi.nlm.nih.gov/pubmed/28809463 http://dx.doi.org/10.1002/cam4.1150 |
_version_ | 1783264775858290688 |
---|---|
author | Chou, Yung‐Chih Lin, Chien‐Yu Pai, Ping‐Ching Tseng, Chen‐Kan Hsieh, Cheng‐En Chang, Kai‐Ping Hsu, Cheng‐Lung Liao, Chun‐Ta Wang, Chun‐Chieh Chin, Shy‐Chyi Yen, Tzu‐Chen Ho, Tsung‐Ying Hong, Ji‐Hong Lei, Kin‐Fong Chang, Joseph Tung‐Chieh Tsang, Ngan‐Ming |
author_facet | Chou, Yung‐Chih Lin, Chien‐Yu Pai, Ping‐Ching Tseng, Chen‐Kan Hsieh, Cheng‐En Chang, Kai‐Ping Hsu, Cheng‐Lung Liao, Chun‐Ta Wang, Chun‐Chieh Chin, Shy‐Chyi Yen, Tzu‐Chen Ho, Tsung‐Ying Hong, Ji‐Hong Lei, Kin‐Fong Chang, Joseph Tung‐Chieh Tsang, Ngan‐Ming |
author_sort | Chou, Yung‐Chih |
collection | PubMed |
description | We aimed to compare the overall survival (OS) of patients with bone metastases (BM) from solid tumors after standard‐dose radiotherapy ([RT]; 30 Gy administered in 10 fractions; EQD(2Gy) = 32.5 Gy) and dose‐escalated RT (EQD(2Gy) > 32.5 Gy). We retrospectively reviewed the clinical charts of 1795 patients (median age, 62.3 years; age range, 18–96 years) with BM from solid tumors who were referred for RT to our institute between 2000 and 2013. These patients were assigned to the standard‐dose (n = 1125; 63%) and dose‐escalated (n = 670; 37%) RT groups. OS, estimated as the duration between the first RT session and death, served as the main outcome measure. The dose‐escalated RT group had a significantly better OS than the standard‐dose RT group (P = 0.000). After allowing potential confounders in multivariate analysis, the RT dose retained its independent association with OS (hazard ratio [HR], 0.837; 95% confidence interval [CI], 0.753–0.929, P = 0.001). After propensity score matching of the baseline characteristics of both groups, RT dose retained its independent association with OS (HR, 0.887; 95% CI, 0.737–0.951; P = 0.011) on multivariate analysis. Dose‐escalated RT exerted more favorable effects on OS in patients with non‐lung cancer, those without multiple metastases, those without symptoms, and those with favorable prognosis. Dose‐escalated RT was significantly associated with better OS in patients with BM from solid malignancies, particularly among those with non‐lung cancer, those without multiple metastases, those without symptoms, and those with favorable prognosis. |
format | Online Article Text |
id | pubmed-5603838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56038382017-09-20 Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study Chou, Yung‐Chih Lin, Chien‐Yu Pai, Ping‐Ching Tseng, Chen‐Kan Hsieh, Cheng‐En Chang, Kai‐Ping Hsu, Cheng‐Lung Liao, Chun‐Ta Wang, Chun‐Chieh Chin, Shy‐Chyi Yen, Tzu‐Chen Ho, Tsung‐Ying Hong, Ji‐Hong Lei, Kin‐Fong Chang, Joseph Tung‐Chieh Tsang, Ngan‐Ming Cancer Med Clinical Cancer Research We aimed to compare the overall survival (OS) of patients with bone metastases (BM) from solid tumors after standard‐dose radiotherapy ([RT]; 30 Gy administered in 10 fractions; EQD(2Gy) = 32.5 Gy) and dose‐escalated RT (EQD(2Gy) > 32.5 Gy). We retrospectively reviewed the clinical charts of 1795 patients (median age, 62.3 years; age range, 18–96 years) with BM from solid tumors who were referred for RT to our institute between 2000 and 2013. These patients were assigned to the standard‐dose (n = 1125; 63%) and dose‐escalated (n = 670; 37%) RT groups. OS, estimated as the duration between the first RT session and death, served as the main outcome measure. The dose‐escalated RT group had a significantly better OS than the standard‐dose RT group (P = 0.000). After allowing potential confounders in multivariate analysis, the RT dose retained its independent association with OS (hazard ratio [HR], 0.837; 95% confidence interval [CI], 0.753–0.929, P = 0.001). After propensity score matching of the baseline characteristics of both groups, RT dose retained its independent association with OS (HR, 0.887; 95% CI, 0.737–0.951; P = 0.011) on multivariate analysis. Dose‐escalated RT exerted more favorable effects on OS in patients with non‐lung cancer, those without multiple metastases, those without symptoms, and those with favorable prognosis. Dose‐escalated RT was significantly associated with better OS in patients with BM from solid malignancies, particularly among those with non‐lung cancer, those without multiple metastases, those without symptoms, and those with favorable prognosis. John Wiley and Sons Inc. 2017-08-15 /pmc/articles/PMC5603838/ /pubmed/28809463 http://dx.doi.org/10.1002/cam4.1150 Text en © 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Chou, Yung‐Chih Lin, Chien‐Yu Pai, Ping‐Ching Tseng, Chen‐Kan Hsieh, Cheng‐En Chang, Kai‐Ping Hsu, Cheng‐Lung Liao, Chun‐Ta Wang, Chun‐Chieh Chin, Shy‐Chyi Yen, Tzu‐Chen Ho, Tsung‐Ying Hong, Ji‐Hong Lei, Kin‐Fong Chang, Joseph Tung‐Chieh Tsang, Ngan‐Ming Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study |
title | Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study |
title_full | Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study |
title_fullStr | Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study |
title_full_unstemmed | Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study |
title_short | Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study |
title_sort | dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603838/ https://www.ncbi.nlm.nih.gov/pubmed/28809463 http://dx.doi.org/10.1002/cam4.1150 |
work_keys_str_mv | AT chouyungchih doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT linchienyu doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT paipingching doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT tsengchenkan doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT hsiehchengen doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT changkaiping doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT hsuchenglung doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT liaochunta doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT wangchunchieh doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT chinshychyi doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT yentzuchen doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT hotsungying doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT hongjihong doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT leikinfong doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT changjosephtungchieh doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy AT tsangnganming doseescalatedradiationtherapyisassociatedwithbetteroverallsurvivalinpatientswithbonemetastasesfromsolidtumorsapropensityscorematchedstudy |